TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31

TALPHERA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$1.08+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $81.57M
P/E (TTM): –
Dividend yield: –

Community

Notes and questions about Talphera from other investors

No posts about TLPH yet

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Talphera's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Nov 14, 2022
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TLPH.

Company	Revenue	Growth
TCRT	$3.00K	-50.0%
TLPH	$1.00K	-96.3%
CVKD	–	–
UNCY	–	–
TENX	$0	–
DMAC	–	–

Company

Next earnings (est.): Nov 11, 2026, during market hours
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 12
Held by institutions: 54.4%
Auditor: BPM LLP
SEC CIK: 1427925

Advertisement
300 × 250